» Articles » PMID: 17598029

Clinical Classification of Itch: a Position Paper of the International Forum for the Study of Itch

Abstract

Chronic itch is a common and distressing symptom that arises from a variety of skin conditions and systemic diseases. Despite this, there is no clinically based classification of pruritic diseases to assist in the diagnosis and cost-effective medical care of patients with pruritus. The proposed classification focuses on clinical signs and distinguishes between diseases with and without primary or secondary skin lesions. Three groups of conditions are proposed: pruritus on diseased (inflamed) skin (group I), pruritus on non-diseased (non-inflamed) skin (group II), and pruritus presenting with severe chronic secondary scratch lesions, such as prurigo nodularis (group III). The next part classifies the underlying diseases according to different categories: dermatological diseases, systemic diseases including diseases of pregnancy and drug-induced pruritus, neurological and psychiatric diseases. In some patients more than one cause may account for pruritus (category "mixed") while in others no underlying disease can be identified (category "others"). This is the first version of a clinical classification worked out by the members of the International Forum for the Study of Itch. It is intended to serve as a diagnostic route for better evaluation of patients with chronic pruritus and aims to improve patients' care.

Citing Articles

Effects and safety of acupuncture versus non-penetrating sham acupuncture for senile pruritus: Rationale and design for a randomized controlled trial.

Chen H, Liu S, Gao S, Yi J, Shi H, Fang J Contemp Clin Trials Commun. 2025; 44:101454.

PMID: 40027278 PMC: 11872407. DOI: 10.1016/j.conctc.2025.101454.


Quality of life and clinical data in hemodialysis patients with different degrees of pruritus.

Fontao S, Manso P, Audije-Gil J, Hernan Gascuena D, Dapena F, Areste N Sci Rep. 2025; 15(1):6222.

PMID: 39979317 PMC: 11842785. DOI: 10.1038/s41598-024-83833-2.


WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses.

Schmidhuber S, Dickie J, Cserepes M, Tovari J, Schneeberger A, Mandler M PLoS One. 2025; 20(2):e0318293.

PMID: 39932924 PMC: 11813111. DOI: 10.1371/journal.pone.0318293.


Patient-Reported Outcomes among people living with Chronic Pruritus (PROs-CP): Protocol for a single-center, multistage, mixed-methods prospective cohort study in Thailand.

Nochaiwong S, Ruengorn C, Kiratikanon S, Rujiwetpongstorn R, Chieosilapatham P, Tovanabutra N PLoS One. 2025; 20(2):e0314548.

PMID: 39928603 PMC: 11809786. DOI: 10.1371/journal.pone.0314548.


Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need.

Bartley B, Pierce C, Hivnor C, Valdes-Rodriguez R Drugs Aging. 2025; 42(3):213-233.

PMID: 39883297 DOI: 10.1007/s40266-024-01174-1.